Literature DB >> 9412703

Clinical implications of autoantibodies in HIV infection.

P S Massabki1, C Accetturi, I A Nishie, N P da Silva, E I Sato, L E Andrade.   

Abstract

OBJECTIVE: To study the frequency and specificity of autoantibodies in HIV-infected subjects and their association with rheumatic manifestations, immunodeficiency, and prognosis.
DESIGN: Prospective study of sequentially selected HIV-infected patients. Indirect immunofluorescence reading was performed by two independent observers blinded for the patient diagnosis. Enzyme-linked immunosorbent assay (ELISA) was performed using coded serum samples.
SETTING: The study was performed at the Infectious Disease and Rheumatology Divisions of a tertiary care university hospital. PATIENTS: One hundred sequentially selected HIV-infected patients formed group A. Controls included 80 non-HIV-infected high-risk individuals (group B), 20 herpesvirus-infected patients (group C), and 30 healthy blood donors (group D). MAIN OUTCOME MEASURES: Patients were followed for 2 years and evaluated for the presence of immunodeficiency, rheumatic manifestations, circulating autoantibodies and total CD4+ cell count. Indirect immunofluorescence was used to investigate antinuclear antibodies, antibodies to native DNA, smooth muscle, parietal cell, glomeruli, thyroid, and neutrophil cytoplasm. Agglutination was used to detect antibodies to erythrocytes and rheumatoid factor. ELISA was used to determine antibodies to cardiolipin and denatured DNA. CD4+ lymphocytes were counted by flow cytometry. Immunoglobulin (Ig) G, IgM and IgA serum levels were determined by radial immunodiffusion.
RESULTS: HIV-infected patients presented higher overall frequency of autoantibodies than the other groups. No difference was observed between immunodeficient and asymptomatic HIV-infected patients. The most frequent specificities were antibodies to cardiolipin and to denatured DNA. Ig serum levels did not correlate with the occurrence of autoantibodies. The presence of autoantibodies was associated with lower CD4+ cell counts and with higher mortality within 2 years. Rheumatic manifestations were observed in 35 HIV-infected patients and were not associated with the occurrence of autoantibodies or the presence of immunodeficiency.
CONCLUSIONS: HIV infection is associated with an increased incidence of autoantibodies. Although not related to the occurrence of rheumatic manifestations, the presence of autoantibodies was significantly associated with lower CD4+ lymphocyte counts and increased mortality, which implies prognostic significance to this phenomenon in the context of HIV infection.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Americas; Antibodies; Autoantibodies; Biology; Brazil; Demographic Factors; Developing Countries; Diseases; Hiv Infections; Immunity; Immunologic Factors; Latin America; Physiology; Population; Population Characteristics; Research Report; South America; Urban Population; Viral Diseases

Mesh:

Substances:

Year:  1997        PMID: 9412703     DOI: 10.1097/00002030-199715000-00009

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  21 in total

1.  The impact of TB and HIV on rheumatic conditions: a reminder from the developing world.

Authors:  Maria Mouyis
Journal:  Clin Rheumatol       Date:  2014-03-08       Impact factor: 2.980

2.  Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection.

Authors:  Douglas H Yamada; Heidi Elsaesser; Anja Lux; John M Timmerman; Sherie L Morrison; Juan Carlos de la Torre; Falk Nimmerjahn; David G Brooks
Journal:  Immunity       Date:  2015-02-10       Impact factor: 31.745

3.  Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy.

Authors:  Zhenwu Luo; Zhen Li; Lisa Martin; Zhuang Wan; Eric G Meissner; Enrique Espinosa; Hao Wu; Xiaocong Yu; Pingfu Fu; Maria Anna Julia Westerink; J Michael Kilby; Jennifer Wu; Lei Huang; Sonya L Heath; Zihai Li; Wei Jiang
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

Review 4.  The Plasticity of Newly Formed B Cells.

Authors:  Natalia V Giltiay; Daniela Giordano; Edward A Clark
Journal:  J Immunol       Date:  2019-12-15       Impact factor: 5.422

5.  Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura.

Authors:  Rahel Froehlich-Zahnd; James N George; Sara K Vesely; Deirdra R Terrell; Khatira Aboulfatova; Jing-Fei Dong; Brenda M Luken; Jan Voorberg; Ulrich Budde; Irmela Sulzer; Bernhard Lämmle; Johanna A Kremer Hovinga
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

6.  Osteonecrosis of the femoral head in patients with type 1 human immunodeficiency virus infection: clinical analysis and review.

Authors:  Jean-Cyr Yombi; Bernard Vandercam; Dunja Wilmes; Jean-Emile Dubuc; Anne Vincent; Pierre-Louis Docquier
Journal:  Clin Rheumatol       Date:  2009-03-10       Impact factor: 2.980

Review 7.  Dermatomyositis and HIV infection: case report and review of the literature.

Authors:  Matthew B Carroll; Robert Holmes
Journal:  Rheumatol Int       Date:  2009-10-24       Impact factor: 2.631

8.  Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7.

Authors:  Angela Malaspina; Susan Moir; Jason Ho; Wei Wang; Melissa L Howell; Marie A O'Shea; Gregg A Roby; Catherine A Rehm; Joann M Mican; Tae-Wook Chun; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

9.  Altered Ratio of T Follicular Helper Cells to T Follicular Regulatory Cells Correlates with Autoreactive Antibody Response in Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Wenjin Fan; Andrew James Demers; Yanmin Wan; Qingsheng Li
Journal:  J Immunol       Date:  2018-04-02       Impact factor: 5.422

10.  Association of progressive CD4(+) T cell decline in SIV infection with the induction of autoreactive antibodies.

Authors:  Takeo Kuwata; Yoshiaki Nishimura; Sonya Whitted; Ilnour Ourmanov; Charles R Brown; Que Dang; Alicia Buckler-White; Ranjini Iyengar; Jason M Brenchley; Vanessa M Hirsch
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.